NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
31/12/2024
Voltar para busca
Dado oficial do USPTO
MRNADVANCE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MRNADVANCE
ST13
US500000098211073Classe
5, 9, 42
Pedido
98211073
Registro
7630312
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
31/12/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 42
Data de depósito
05/10/2023
Data de registro
31/12/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/12/2024
Última transação
31/12/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Yeonsu-gu, Incheon, KR
Examinador
BLAZICH, JOAN MICHELE
Unidade examinadora
N40
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Samsung Biologics Co., Ltd.
Representantes
Lisa C. Pavento MEUNIER CARLIN & CURFMAN LLC
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Reagents for medical use for measurement of HBs antibody; medicines consisting of RNA for treating cancer; crude medicines for treating ocular diseases; cellular function activating agents for medical purposes; colostral antibodies for veterinary purposes; chemico-pharmaceutical preparations for treating cancer; chemical preparations for use in DNA analysis for medical purposes; chemical preparations for use in RNA analysis for medical purposes; bacterial preparations for medical and veterinary use; chemical preparations for treating cancer for medical or veterinary purposes; biotechnological preparations for medical purposesreagents for medical purposes; biological reagents for medical purposes; biochemical preparations for medical purposes; reagents for medical use; bispecific colostral antibody for medical use; trace element preparations being dietary supplements for human use; clinical medical reagents; pharmaceutical preparations for the treatment of cancer; medical diagnostic reagents for the detection of mRNA antigens; colostral antibodies for medical purposes
Classe 9
DNA analysis apparatusmedical laboratory research instruments for DNA analysis; DNA chips; RNA microarrays; cartridges for storing specimen used for RNA analysis apparatussolid phase extraction cartridges for laboratory use; reagent cartridges used for RNA analysis apparatussolid phase extraction cartridges for laboratory use; reagent containers used for RNA analysis apparatussolid phase extraction cartridges for laboratory use; RNA analysis apparatusmedical laboratory research instruments for RNA analysis; RNA sequencing deviceslaboratory devices for detecting genetic sequences; RNA chips; genome analyzer machineslaboratory devices for detecting genetic sequences and related downloadable computer operating software; devices for analyzing genome informationlaboratory devices for detecting genetic sequences; bioreactors for cell culturing for scientific research; biochip analyzing apparatus for research or scientific purposes; biochip sensors for sensing antigens; biochips for research or scientific purposes; liquid dosage devices that measure the amounts to be dispenseddispensers for measuring and dispensing of distilled waternot for medical use; incubators for cell culturenot for medical purposes; cellchip inspectors being optical inspection apparatus; devices for analyzing protein sequence used as laboratory apparatuslaboratory devices for detecting genetic sequences; physical and chemical machines for laboratory use; physical and chemical apparatus for analyzing geneslaboratory devices for detecting genetic sequences; gene amplifiers being DNA microarrays; mRNA microarrays; RNAMRNADNA microarrays; nucleic acid sequencing devices and nucleic acid synthetic apparatuslaboratory devices for detecting genetic sequences; diagnostic chips for inspecting blood plasma laboratory apparatusDNA chips; diagnostic chips for analyzing blood plasma laboratory apparatusDNA chips
Classe 42
RNA technology research and development; providing temporary use of non-downloadable web application for sharing information in the RNA technology field; research in the field of RNA repair technology; research and development of RNA chips; research relating to sciencescientific research in the field of RNA; RNA screening for scientific research purposes; RNA sequence analysis for scientific research purposes; multiple nucleic acid analysis for scientific research purposes; molecular analysis for scientific research purposes; development of new technology for others in the field of biotechnology; biochemical analysis; drug discovery services; design of new products for others; pharmaceutical research and development; clinical studies of medicinesconducting clinical trials for others; services for assessing the efficiency of pharmaceuticalsproduct quality testing services; fusion protein analysis for scientific research purposes; computer programming services in the medical field; medical laboratories; management assistance services for medical image dataengineering services; medicine research being medical research; analysis and evaluation of medical product developmentproduct quality testing services; providing scientific information on the testinginspection and research of medical products; scientific and medical laboratory services relating to the production of bispecific antibody antibodies; pharmaceutical drug development for bispecific antibody; bispecific antibody research and development; evaluating of clinical trial progressconducting clinical trials for others; clinical trialsconducting clinical trials for others; providing temporary use of onlinenon-downloadable computer operating software for genome analyzer machines
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
31/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/11/2024
PUBO
PUBLISHED FOR OPPOSITION
12/11/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23/10/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/10/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
24/09/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
24/09/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
24/09/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
24/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/09/2024
ALIE
ASSIGNED TO LIE
13/09/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
26/04/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/02/2024
GNSL
LETTER OF SUSPENSION E-MAILED
08/02/2024
CNSL
SUSPENSION LETTER WRITTEN
08/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/01/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/11/2023
GNRT
NON-FINAL ACTION E-MAILED
07/11/2023
CNRT
NON-FINAL ACTION WRITTEN
07/11/2023
DOCK
ASSIGNED TO EXAMINER
30/10/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/10/2023
NWAP
NEW APPLICATION ENTERED
09/10/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MRNADVANCE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.